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ABSTRACT
Methamphetamine (METH), a highly addictive
drug used worldwide, induces oxidative stress
in various animal organs. Recent animal studies
indicate that methamphetamine also induces
oxidative stress in the retina, which is an embryonic extension of the forebrain. The aim of
this study, therefore, was to evaluate the protecttive effects of N-acetylcysteine amide (NACA)
against oxidative stress induced by METH in
retinal pigment epithelium (RPE) cells. Our studies showed that NACA protected against METHinduced oxidative stress in retinal pigment
epithelial cells. Although METH significantly decreased glutathione (GSH) levels and increased
reactive oxygen species (ROS) and malondialdehyde (MDA) levels, these returned to control
levels with NACA treatment. Overall observations indicated that NACA protected RPE cells
against oxidative cell damage and death by inhibiting lipid peroxidation, scavenging ROS, increasing levels of intracellular GSH, and maintaining the antioxidant enzyme activity and the
integrity of the bloodretinal barrier (BRB). The
effectiveness of NACA should be further evaluated to determine its potential for the treatment
of numerous retinal diseases caused by oxidative stress.
Keywords: Methamphetamine; Oxidative Stress;
Antioxidant; Reactive Oxygen Species;
N-Acetylcysteine Amide; Blood-Retina Barrier

1. INTRODUCTION
Methamphetamine (METH), a highly addictive psychostimulant, is abused by approximately 35 million people
Copyright © 2012 SciRes.

worldwide [1]. A dramatic increase in METH-related
emergency department visits is alarming, with >50%
involving young adults between the ages of 18 - 34 years
[2]. The relative ease of METH’s availability, coupled
with its toxicity, has resulted in increased numbers of
associated medical complications and fatalities [2,3].
Oxidative stress is believed to play a crucial role in
METH-induced toxicity and is supported by several
studies which reported decreased glutathione (GSH) levels,
reduced levels and activities of antioxidant enzymes, and
increased lipid peroxidation and protein carbonylation,
all hallmarks of oxidative stress [4-8]. In the case of the
brain, it is believed that, initially, METH causes a massive release of dopamine by inhibiting monoamine oxidase activity and dopamine uptake [9]. With higher doses,
however, it causes dopamine depletion by degenerating
dopaminergic terminals, damaging dopaminergic neurons,
and decreasing dopamine transporter numbers [10,11].
Dopamine then reacts with molecular oxygen to form
reactive oxygen species (ROS), such as hydrogen peroxide, superoxide, and hydroxyl free radicals, resulting in a
condition known as oxidative stress [11] and causes
neuronal death by apoptosis [12].
Oxidative stress acts as a propagating force in the
pathogenesis of many ocular disorders, including cataracts, glaucoma, diabetic retinopathy, HIV-related retinopathy, and age-related macular degeneration (AMD)
[13-15]. Oxidative stress possibly contributes to the death of
retinal cells and degeneration of the macula [16-20]. Free
radical formation in a developing retina has been reported to be induced by xenobiotics, e.g., environmental
pollutants, pharmacological substances, and alcohol [21].
METH abuse is implicated in a number of serious
ocular pathologies, including corneal ulceration, retinal
vasculitis, episcleritis, scleritis, panophthalmitis, endophthalmitis, and retinopathy [22-24]. It has been reported
that METH induces oxidative stress in the retina and
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adversely affects the dopaminergic system of the rat retina
[25], particularly during central nervous system (CNS)
development. Prudencio et al. [26] demonstrated that
METH altered retinal plasma membrane integrity, esterase activity, and/or pH in rat retina homogenates. Another study reported exacerbation of damaging effects of
kainic acid on the retina by METH [27]. Under physiological conditions, high levels of antioxidant enzymes
and small antioxidant molecules, particularly glutathione
(GSH), in the Muller (glial) cells protects retinal pigment
epithelium (RPE) cells against oxidative stress. GSH in
the Muller cells is depleted under oxidative stress and,
since GSH cannot be transported directly into the cells,
the need arises for permeable compounds that can increase
intracellular GSH levels. One such compound, known to
increase intracellular GSH levels in cells, is the low molecular weight thiol antioxidant, N-acetylcysteine amide
(NACA). Previous work by our group has demonstrated
that NACA restored the levels of GSH, and scavenged
the ROS produced in human brain endothelial cells, upon
treatment with METH [4].
Even though the adverse effects of METH on the brain
are linked to oxidative stress, little is known about its
effect on the retina. Considering the ability of NACA to
protect cells from oxidative stress [28-30], the effectiveness of this antioxidant was evaluated as a treatment option for METH-induced oxidative damage to RPE cells.
Understanding NACA’s protective role against METHinduced oxidative damage to RPE cells would help develop NACA as a potential therapeutic agent for treating
RPE cells against numerous oxidative stress-related ocular
diseases.

2. MATERIALS AND METHODS
2.1. Materials
The retinal pigment epithelial cell line, ARPE-19, was
purchased from the American Type Culture Collection
(ATCC # CRL-2302) (Manassas, VA), and the N-acetylcysteine amide (NACA) from Dr. Glenn Goldstein of
David Pharmaceuticals in New York, NY. HPLC chemicals
were obtained from Fisher Scientific (Pittsburgh, PA).
Cell culture reagents were purchased from ATCC in Manassas, VA, and Calcein AM was bought from Biotium, Inc.
(Hayward, CA). The National Institute on Drug Abuse
(NIDA) provided methamphetamine, while other chemicals were obtained from Sigma-Aldrich (St. Louis, MO),
unless otherwise stated.

2.2. ARPE-19 Cell Culture and Treatment
The ARPE-19 cells were cultured in a one-to-one ratio
of DMEM: F-12 culture medium, and supplemented with
10% (v/v) FBS, 100 U/mL of penicillin, and 100 μg/mL
of streptomycin. Cells were maintained in a 37˚C incubator
Copyright © 2012 SciRes.

and supplied with 95% air and 5% CO2. Cells between
passage numbers 26 and 32 were used for experiments.

2.3. Determination of Cell Viability
The ARPE-19 cells were seeded in a 96-well tissue
culture plate, at a density of approximately 1.25 × 104
cells/well, for a day. The media was then discarded and
the cells were treated with various concentrations of METH
and NACA in serum-free media for 24 hours and 2 hours,
respectively. Protective effects of NACA were studied by
pre-incubating cells with NACA for 2 hours, followed by
treatment with 500 µM of METH for 24 hours. After 24
hours of METH treatment, the medium was discarded
and a Calcein AM assay KIT (Biotium, Inc. CA) was
used to determine cell viability relative to the control
group [31]. The cells were then washed three times with
PBS, and 100 µL of 2.0 M Calcein AM in PBS were
added to each well for 30 minutes at 37˚C. The fluorescence was measured with an excitation wavelength at
485 nm and an emission wavelength of 530 nm, using a
microplate reader (FLUOstar, BMG Labtechnologies,
Durham, NC, USA).

2.4. Intracellular ROS Measurement
Intracellular ROS generation was measured using a
well-characterized probe, 2’, 7’-dichlorofluorescin diacetate (DCFH-DA) [32]. ARPE-19 cells were seeded at a
density of 1.25 × 104 cells/well in a 96-well plate.
DCFH-DA is hydrolyzed by esterases to dichlorofluorescin (DCFH), which was trapped within the cell. This
nonfluorescent molecule is then oxidized to fluorescent
dichlorofluorescin (DCF) by the action of cellular oxidants. In groups with NACA pretreatment, media containing 1 mM NACA was added and incubated for 2
hours. Once pretreated, the cells were washed twice with
PBS and incubated with a solution of 50 μM DCFH-DA
in phenol red free media for 30 minutes. This was followed
by washing the cells twice with PBS, and the respective
groups were then dosed either with 500 µM METH or
plain media for 4 hours and then fluorescence was determined at 485 nm excitation and 520 nm emission, using
a microplate reader (FLUOstar, BMG Labtechnologies,
Durham, NC, USA).

2.5. Experimental Design for Oxidative
Stress Parameters
Parameters, including GSH, MDA, and activities of
glutathione peroxidase and catalase, were measured after
the cells were treated, as described below. After seeding
the cells, the flasks were divided into the following four
groups: 1) control; 2) NACA-only; 3) METH-only; and 4)
METH + NACA. In groups with NACA pretreatment,
media containing 1 mM NACA was added and incubated
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for 2 hours. After pretreatment, the media in the control
and NACA-only groups were replaced with plain media,
while both of the remaining two groups received media
containing METH for 24 hours. The cell pellets obtained
were then further processed for appropriate assays.
2.5.1. Determination of Glutathione (GSH)
The levels of GSH in the tissues were determined by
RP-HPLC, according to the method developed in our
laboratory [33]. The HPLC system (Thermo Electron Corporation) consisted of a Finnigan Spectra System vacuum
membrane degasser (model SCM1000), a gradient pump
(model P2000), autosampler (model AS3000), and a
fluorescence detector (model FL3000) with ex = 330 nm
and em = 376 nm. The HPLC column used was a
Reliasil ODS-1 C18 column (5 µm packing material)
with 250 mm × 4.6 mm i.d. (Column Engineering,
Ontario, CA). The mobile phase (70% acetonitrile and
30% water) was adjusted to a pH of 2 with acetic acid and
o-phosphoric acid. The N-(1-pyrenyl)-maleimide (NPM)
derivatives of GSH were eluted from the column isocratically at a flow rate of 1 mL/min. The cell samples
were homogenized in a serine borate buffer (100 mM
Tris HCl, 10 mM borate, 5 mM serine, 1 mM diethylenetriaminepentaacetic acid), centrifuged, and 50 µL of the
supernatant were added to 230 µL of HPLC grade water
and 750 µL of NPM (1 mM in acetonitrile). The resulting
solution was incubated at room temperature for 5 minutes,
and the reaction was stopped by adding 10 µL of 2 N
HCl. The samples were then filtered through a 0.45 µm
filter and injected into the HPLC system.
2.5.2. Determination of Malondialdehyde (MDA)
The MDA levels were determined according to the
method described by Draper et al. [34]. Briefly, 550 µL
of 5% tricholoroacetic acid (TCA) and 100 µL of 500
ppm butylated hydroxytoluene (BHT) in methanol were
added to 350 µL of the cell homogenates, and boiled for
30 minutes in a water bath. After cooling on ice, the mixtures were centrifuged, and the supernatant collected was
mixed 1:1 with saturated thiobarbituric acid (TBA). The
mixture was again heated in a water bath for 30 minutes,
followed by cooling on ice. 500 µL of the mixture was
extracted with 1 mL of nbutanol and centrifuged to facilitate the separation of phases. The resulting organic
layers were first filtered through 0.45 µm filters and then
injected into the HPLC system (Shimadzu, US), which
consisted of a pump (model LC-6A), a Rheodyne injection
valve and a fluorescence detector (model RF 535). The
column was a 100 mm × 4.6 mm i.d. C18 column (3 µm
packing material, Astec, Bellefonte, PA). The mobile
phase used contained 69.4% sodium phosphate buffer,
30% acetonitrile, and 0.6% tetrahydrofuran. The fluorescent product was monitored at ex = 515 nm and em = 550
Copyright © 2012 SciRes.
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nm. The concentrations of the TBA-MDA complex in the
mixture was determined by using the calibration curve
obtained from a 1,1,3,3,-tetraethoxypropane standard solution. This method differs from commonly used TBARS
assay in that it specifically determines TBA-MDA adducts
by HPLC.
2.5.3. Measurement of Catalase (CAT) Activity
Catalase activity was measured according to the method
described by Aebi [35]. Briefly, it was measured spectrophotometrically at a wavelength of 240 nm, in the supernatant of the cell homogenate, following the exponential
disappearance of hydrogen peroxide (H2O2, 10 mM). The
catalase activity was calculated from the equation A60 =
Ainitiale–kt, where k represents the rate constant, Ainitial is
the initial absorbance and A60 is the absorbance after 60
seconds have passed.
2.5.4. Measurement of Glutathione Peroxidase
Activity
Glutathione peroxidase (GPx) activity was determined
using a glutathione peroxidase colorimetric assay kit purchased from Oxis Research (Foster City, CA). The cell
samples were homogenized in 50 mM of phosphate
buffer (pH 7.4), containing 1.0 mM EDTA, and then
centrifuged at 7500 × g for 10 minutes. The resulting
supernatant was collected to be used for the assay while
the remaining debris was discarded. In brief, the assay
buffer, supernatant, and NADPH reagent (containing
glutathione reductase, GSH, and NADPH) were placed
in a cuvette and the reaction initiated by the addition of
t-butylhydroperoxide (tBHP). The decrease in absorbance at
340 nm was recorded for 3 minutes and the change in
A340/min from the initial linear portion of the curve was
used to calculate the GPx enzyme activity. The GPx
activity was calculated using the extinction coefficient of
NADPH (6220 M–1·cm–1) and expressed as U/mg of
protein.
2.5.5. Dextran Permeability Study and
Trans-Endothelial Electrical Resistance
(TEER) Measurement
ARPE-19 cells were seeded at a density of 1.5 × 105
cells/well onto collagen-coated inserts with a pore size of
0.4 µm and allowed to form a monolayer. Trans-endothelial electric resistance (TEER) measurement by an
EVOM voltohmmeter (World Precision Instrument,
Sarasota, FL, USA) assessed the tightness of the ARPE
monolayer [4]. The cell monolayer was then treated as
described in Experimental Design. After this, the media
was replaced with 150 µL of fresh medium. The insert
containing the cell monolayer was then transferred to a
fresh plate containing 500 µL of serum-free medium. The
TEER reading was recorded immediately and TEER
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values were calculated as: Resistance × 0.32 cm2 (insert
surface area). Thus, resistance is proportional to the effective membrane.

2.6. Determination of Protein
Protein levels of the cell samples were measured by
the Bradford method [36] using bovine serum albumin as
standard.

2.7. Statistical Analysis
Statistical significance was calculated using an unpaired
two-tailed student’s t test in which “*” represents a
p-value ≤ 0.05 when compared to the control group, and
“**” represents a p-value ≤ 0.05 when compared to the
METH group. All reported values were represented as
mean ± S.D. of triplets.

(a)

3. RESULTS
3.1. Protection from METH Toxicity
Cell viability was measured as a function of METH
and NACA dose to determine the optimum concentrations for both METH and NACA, respectively. Figures
1(a) and (b) revealed that a concentration of 500 µM
METH and 1 mM NACA are the minimum toxic doses
of METH and NACA, for ARPE-19 cells and, therefore,
these doses were selected for further experiments. Figure
2 shows that pretreatment with 1.0 mM of NACA successfully protected the ARPE-19 cells from METHinduced death, thereby increasing viability to ~92% of
that of control levels.

3.2. Intracellular ROS Measurements
After treatment with 500 µM of METH, ROS production
was found to have increased. METH (500 µM) induced
an increase in the DCF fluorescence by approximately
30%, as compared to that of the control (Figure 3), while
pretreatment with 1 mM NACA (2 hours prior to exposure)
completely erased this increase. NACA alone did not
significantly alter DCF fluorescence compared to that of
the control.

3.3. Intracellular Glutathione
Figure 4 shows the effect of METH on cellular GSH
levels in ARPE-19 cells in the presence and absence of
NACA. A 24-hour exposure to METH resulted in an
increase in cellular oxidative stress. Treatment with 500
µM of METH altered the GSH level to 80% of that of the
control. A 500 µM treatment of METH, with a 1 mM
pretreatment of NACA, was significantly different from
that of the METH group alone, with p ≤ 0.05 and a GSH
concentration of 98% of that of the control group. The

Copyright © 2012 SciRes.

(b)

Figure 1. Cell viability of ARPE-19 cells. (a) Cell
viability after varying treatments with METH for
24 hours. A concentration of 500 µM was found to
be the minimum toxic dose of METH for ARPE19 cells and was used as the optimum dose for all
experiments. Values are represented as mean ±
S.D. (*) refers to significant differences from the
control with p ≤ 0.05. The graph is representative
of at least three independent experiments; (b) Cell
viability of ARPE-19 cells after treatment with
NACA for 2 hours. ARPE-19 cells were treated
with various concentrations of NACA (0.5 mM, 1
mM, and 2 mM). After 2 hours of treatment, cell
viability was quantified by a Calcein AM assay
and a concentration of 1 mM NACA was used for
the rest of the experiments in this study. Values are
represented as mean ± SD.

NACA alone treated group was found to have no significant changes in the GSH levels, as compared to that of
the control group.

3.4. Lipid Peroxidation Byproduct: MDA
MDA was used as an index of lipid peroxidation. MDA
levels were determined in ARPE-19 cells pretreated with
NACA for 2 hours, followed by exposure to METH for
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Figure 2. Cell viability of ARPE-19 cells after treatment with METH and NACA. Cell viability was
quantified by a Calcein AM assay 24 hours after exposure to METH, following a 2-hour pretreatment
with NACA. Treatment with METH (500 µM) alone
was seen to significantly decrease cell viability. NACA
(1.0 mM) was seen to protect against some METHinduced cell toxicity. *p ≤ 0.05 compared to the control group, and **p ≤ 0.05 compared to the corresponding value of the METH group.

Figure 3. ROS levels in ARPE-19 cells after treatment
with METH and NACA. ROS levels were measured after
4 hours of treatment for control, NACA, METH, and
METH + NACA groups. The ROS level in the NACAonly group was very similar to that of the control group.
However, a concentration of 500 µM of METH signifycantly decreased the ROS level (*p ≤ 0.05). Pretreatment
with 1 mM of NACA returned the ROS level to near that
of the control level (**p ≤ 0.05). The results are representative of at least three independent experiments.

24 hours. METH-treated cells had significantly higher
levels (about four fold) of MDA, as compared to those of
the control (Figure 5). Pretreatment with 1 mM of NACA
completely reduced this increase, with MDA levels
becoming nearly the same as those of the control. The
NACA-only treated group showed no significant difference
when compared to the control.
Copyright © 2012 SciRes.

Figure 4. Intracellular GSH levels in ARPE-19
cells after treatment with METH and NACA. GSH
levels were measured after 24 hours of treatment
for control, NACA, METH, and METH + NACA
groups. The GSH level in the NACA-only group
was similar to that of the control. Exposure to
METH (500 µM) significantly decreased intracellular GSH (*p ≤ 0.05). Pretreatment with NACA (1
mM), 2 hours before the addition of METH, prevented such a dramatic decrease (**p ≤ 0.05). At
least three independent experiments were performed.

Figure 5. MDA levels in ARPE-19 cells after
treatment with METH and NACA. It was found
that after 24 hours the MDA levels significantly
increased. MDA levels in the NACA-only group
were very similar to those of the control group;
therefore, this was not included in the figure.
METH (500 µM) induced a significant increase in
the MDA level. Addition of 1 mM of NACA pretreatment decreased lipid peroxidation significantly
below that of METH alone. Values represent the
mean ± SD. “*” refers to significant differences
from the control with p ≤ 0.05 and “**” refers to
the significant differences from the METH-only
group. The graph is representative of three independent experiments.

3.5. Catalase and Glutathione Peroxidase
Activity
Effects of METH on the enzyme activities of catalase
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(CAT) and glutathione peroxidase (GPx) were measured
(Table 1). METH administration markedly decreased the
levels of GPx and CAT enzyme activities by about 30%,
as compared to the control group. Pretreatment with
NACA significantly attenuated this decrease to 10% of
the control GPx activity level but didn’t alter the CAT
activity level. In both of these experiments, NACA alone
did not significantly alter the results from those of the
control group; all experiments were conducted in triplicate.

3.6. Dextran Permeability and TEER Assays
The cell permeability assay and TEER are especially
important in this study because they simulated the integrity
of the BRB. Permeability studies showed that treatment
with 500 µM of METH increased permeability by
approximately 15%, as compared to that of the control
(Figure 6(a)), while pretreatment with NACA significantly reduced this permeability to levels similar to that
of the control group. As in the permeability study, TEER
results (as shown in Figure 6(b)) also indicate the protective effect of NACA. Exposure to 500 µM resulted in a
decrease in TEER by about 10%, as compared to that of
the control, while pretreatment with NACA gave resistance
values only slightly less than control levels. Treatment
with NACA alone did not significantly alter TEER, as
compared to that of the control. All experiments were
conducted in triplicate.

4. DISCUSSION
Retinal pigment epithelial (RPE) cells form a nonrenewable monolayer of specialized cells derived from the
neuroectoderm and are present at the interface between
choroidal capillaries and the neurosensory retina. They
play numerous roles, including regulation of ion and metabolite transport, phagocytosis of shed photoreceptor
outer segments, metabolism of retinol, formation of the
outer blood-retinal barrier, maintenance of the extracellular matrix, and metabolism of numerous potential
Table 1. Catalase and GPx activity in ARPE-19 cells after
treatment with Meth and NACA.
Group

CAT
(mU/mg protein)

GPx
(mU/mg protein)

Control

19.5 ± 3.1

56.6 ± 9.8

NACA only

20.1 ± 5.2

59.5 ± 8.4

Meth only

14.1 ± 0.6*

39.2 ± 1.7*

Meth + NACA

19.1 ± 7.8

51.0 ± 7.4**

Values represent the mean ± SD. “*” refers to significant differences from
the control with p ≤ 0.05 and “**” refers to the significant differences from
the METH-only group. The values are representative of three independent
experiments.

Copyright © 2012 SciRes.

(a)

(b)

Figure 6. Protective effects of NACA on dextran permeability or TEER for ARPE-19 cells
treated with METH. Cells were seeded onto a
collagen-coated insert with a pore size of 0.4
μm at a density of 1.5 × 105/well, and allowed
to culture until a monolayer formed. The cell
monolayer was then treated with 500 µM of
METH with or without the 2-hour pretreatment
using 1 mM of NACA for 24 hours. (a) Significantly higher permeability of dextran across
the cell monolayer was observed after treatment
with METH, as compared to the control (*p ≤
0.05). Pretreatment with NACA, however, was
shown to reduce this permeability (**p ≤ 0.05)
to levels similar to control values; (b) Cells
treated with only METH resulted in signifycantly decreased TEER values, as compared
with both control (*p ≤ 0.05) and METH +
NACA (**p ≤ 0.05) groups. At least three independent experiments were performed for dextran permeability or TEER assays.

toxins, such as the free radicals and peroxides [37]. Dysfunction of the retinal pigment epithelium (RPE) is implicated in many ocular pathologies, including vision loss.
Oxidative effects of METH on RPE cells have not
been extensively studied, despite the fact that METH
abuse is quite prevalent worldwide, due to the euphoria
produced, its wide availability, and relatively low cost.
Herein, we report the in vitro effects of METH on human
OPEN ACCESS
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retinal cells (ARPE-19 cell line) and the role of a novel
thiol antioxidant, N-acetylcysteine amide (NACA), in
preventing RPE cell death and maintaining RPE redox
status.
METH-treated ARPE cells showed a significant increase
in ROS accumulation, indicating oxidative stress. This
resulted in depletion of GSH, the key thiol antioxidant,
leading to disruption of the thiol redox state and, ultimately, cell death. A possible explanation for a decrease in
GSH levels is the reduced activity of the enzymes involved
in GSH synthesis and/or the oxidation of GSH to GSSG
under oxidative stress. Pretreatment with NACA increased the GSH levels and cell viability in the METHtreated group, indicating that NACA had replenished the
GSH levels in these cells and prevented oxidative stressinduced cell death. These results are also in accordance
with our previous study on METH-induced toxicity [4].
The protective effect of NACA is probably mediated by
NACA’s ability to increase GSH biosynthesis by reducing
extracellular cystine to cysteine, and/or by supplying the
sulfydryl groups that can stimulate GSH biosynthesis, or
by conversion of GSSG to GSH [38].
Lipid peroxidation is thought to play an important role
in the pathogenesis of age-related macular degeneration,
and is a consequence of increased levels of ROS in the
macula [39]. The membranes of outer segments of photoreceptors are rich in polyunsaturated fatty acids (PUFAs),
which are highly susceptible to radical damage and
peroxidation [40]. Increased levels of lipid peroxidation
products can also lead to lysosomal dysfunction in the
RPE [39]. Therefore, MDA, an important lipid peroxidation by-product, showed a significant increase in the
levels when measured in ARPE-19 cells treated with
METH. Lipid peroxidation is a key mechanism by which
METH and its radicals induce cell death. It has been
postulated that radicals attack membrane lipids and
initiate a chain of events leading to lipid peroxidation
[41,42]. Pretreatment with NACA successfully reversed
the increase in MDA levels, indicating that NACA can
protect RPE cells from lipid peroxidation. Preventing
this is important for improving RPE lysosomal function,
as highlighted in a study of the effects of N-acetylcysteine on lysosomal volume and metabolism in RPE cells
loaded with regular or oxidized human and porcine rod
outer segments [43]. These results are also in line with a
previously reported increase in MDA levels [25]. Concomitant reduction of GSH levels (a substrate for glutathione peroxidase) might have hampered the decomposition of lipid peroxides in METH-treated animals. NACA
was able to break lipid peroxidation chain reaction by
supplying an adequate amount of GSH as a substrate for
glutathione peroxidase to effectively decompose lipid
peroxides, thus reducing MDA levels.
Antioxidant enzymes are involved in the detoxification
Copyright © 2012 SciRes.
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of lethal peroxides inside the cells. A significant reduction in the activity of GPx and catalase was observed
after METH treatment. A decrease in GPx activity may
have been partially due to diminished GSH levels that
GPx needs as a substrate. We previously reported decreased
GPx activity, due to METH, in human brain microvascular endothelial cell culture [36]. Our results are also in
accordance with the previously reported decrease in GPx
activity after METH administration [44-47]. In contrast,
the increased GPx activity in rat brains, observed by
Flora et al. [48] after METH administration, could have
been due to the enhanced levels of cellular glutathione
observed in their study. On the other hand, no change in
GPx activity in rat brains was reported by Moszczynska
et al. [6] in response to METH.
A decrease in catalase activity has been reported for
various tissues undergoing oxidative stress [49]. However,
an increase in catalase activity in RPE cells, challenged
with H2O2, has also been reported [50]. On the other
hand, Melo et al., [51] were unable to find differences in
the catalase activity in the retinas of METH-treated rats.
The response of this antioxidant enzyme to oxidative
agents could be tissue/organ specific and may be adaptive. So far, it is poorly understood through which mechanisms METH affects the function of catalase. However it is thought that the tyrosyl radical in the catalase
enzyme is involved in the catalytic activity of the enzyme
[52,53]. Nitration or a reaction of free radicals with this
tyrosine residue could lead to inactivation of the enzyme.
Phosphorylation of the tyrosine residue on catalase has
also been reported and may lead to decreased activity of
the catalase enzyme [54]. NACA pretreatment maintained GPx and catalase activity in the METH + NACA
group, possibly due to the scavenging of free radicals by
NACA and by providing GSH, which is a substrate for
GPx.
In the retina, the RPE forms the blood-retinal barrier
(BRB) by forming tight junctions that control the exchange of nutrients and metabolites between the retina
and the underlying choriocapillaries. It is thought that
oxidative stress may induce changes in the BRB, which
may contribute to the pathogenesis of retinal degeneration. It was, therefore, important to determine if NACA
could protect the junctional integrity of ARPE-19 cells
exposed to oxidative stress. NACA prevented a METHinduced decrease in TEER which led to protection of
cellular homeostasis and outer BRB integrity. A similar
decrease in TEER has been reported in another study,
where ARPE-19 cells were exposed to hydrogen peroxide [55].

5. CONCLUSIONS
This study demonstrates that METH induces oxidative
stress in ARPE cells by depleting GSH and that NACA, a
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GSH prodrug, protected ARPE cells against METHinduced oxidative damage, possibly by a variety of mechanisms, including scavenging of ROS; increasing the
activity of the detoxification enzyme, glutathione peroxidase (GPx), by providing GSH which is a limiting substrate
for GPx activity and halting the production of further
ROS and lipid peroxidation. GSH might also provide
protection by recycling other key antioxidants like
vitamin E and vitamin C.
A logical approach, therefore, to enhancing antioxidant protection, would be the use of pharmacologic
doses of highly-active antioxidants that can be delivered
to the sites of damage caused by ROS. Epidemiological
data supports the beneficial effects of antioxidant supplementation to decrease these oxidative processes in the
retina and retinal pigment epithelium [56]. Studies have
shown protective effects of NACA against radiationinduced toxicity, HIV-protein-induced oxidative stress,
allergic airway disease, pollutant-induced lung disease,
and lead-induced cell death [29-31,49].
The development of a useful antioxidant agent in the
form of eye drops would significantly improve the severity of eye disorders in METH abusers. Our current and
future work would provide additional momentum for
research on antioxidant-based approaches to treating degenerative eye conditions. Further investigation could
help determine NACA’s efficacy in METH-abuse treatment and an evaluation of the histology in METH-treated
animals would provide additional information on it’s therapeutic potential. Remarkable protection shown by
NACA in previous studies indicates that NACA may be
developed into a potential treatment option in the prevention or delay of numerous retinal diseases caused by
oxidative stress, including METH abuse.
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